Dipeptidyl Peptidase-4 Inhibitors and the Risk of Pancreatitis in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study

Figure 3

Kaplan–Meier plots for hospitalization for acute pancreatitis in male patients (a), female patients (b), patients aged ≥ 65 years (c), patients aged < 65 years (d), patients with DM microvascular complications (e), and patients without DM microvascular complications (f). DM: diabetes mellitus; DPP-4i: dipeptidyl-peptidase IV inhibitor; N: number of patients; SU: sulfonylurea; y: year(s).

(a)

(b)

(c)

(d)

(e)

(f)